Get started
Author

Virginie Roland

Observed names: Roland V, Roland, Virginie, V Roland, V. Roland
ORCID: 0000-0003-1108-488X
Observed ORCID: 0000-0003-1108-488X
OpenAlex ID: A5048473990
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study
2024 · Aurélie Jourdes, Elise Cellerin, et al. · Clinical Microbiology and Infection · 88
PDF
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
2005 · Patrice Chevallier, Virginie Roland, et al. · Leukemia Research · 37
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
2022 · Paul Lesueur, Gandhi Damaj, et al. · Blood Advances · 34
PDF
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
2015 · J. Lazarovici, P. Dartigues, et al. · Haematologica · 34
PDF
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
2025 · Anaïs Schavgoulidze, Aurore Perrot, et al. · Blood · 26
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network
2022 · Laurence Schenone, Caroline Houillier, et al. · Bone Marrow Transplantation · 26
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients
2010 · V Roland, C Bodet-Milin, et al. · Bone Marrow Transplantation · 25
Vowel production: a potential speech biomarker for early detection of dysarthria in Parkinson’s disease
2023 · Virginie Roland, Kathy Huet, et al. · Frontiers in Psychology · 23
PDF
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study
2022 · Antoine Bonnet, Céline Bossard, et al. · Cancer Medicine · 16
PDF
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins ( FB 2 regimen) reduced‐intensity conditioning regimen ( RIC ) allogeneic stem cell transplantation (allo‐ SCT )
2013 · Amandine Le Bourgeois, Elsa Lestang, et al. · European Journal Of Haematology · 16
Is ASCT With TBI Superior to ASCT Without TBI in Mantle Cell Lymphoma Patients?
2012 · Pierre Peterlin, Christophe Leux, et al. · Transplantation · 13
Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma
2012 · Cyrille Touzeau, Nicolas Blin, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
2024 · Caroline Dartigeas, Anne Quinquenel, et al. · Annals of Hematology · 10
PDF
Cumulative Incidence and Characteristics of Infections Requiring Treatment, Delay in Treatment Administration or Hospitalisation in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti BCMA or Anti GPRC5D Bispecific Antibodies
2023 · Elise Cellerin, Aurelie Jourdes, et al. · Blood · 5
The Production of Intervocalic Glides in Non Dysarthric Parkinsonian Speech
2016 · V. Delvaux, V. Roland, et al. · Interspeech (USB) · 5
PDF
High-Risk Multiple Myeloma in Benefit (IFM 2020-05) Phase 3 Randomized Study of Isatuximab (Isa) Plus Lenalidomide and Dexamethasone (Rd) with Bortezomib Versus Isard in Patients with Newly Diagnosed Transplant Ineligible Multiple Myeloma (NDMM TI)
2024 · Jill Corre, Jérôme Lambert, et al. · Blood · 4
5-Azacytidine (AZA) Compared to Intensive Chemotherapy in Elderly Acute Myeloid Leukemia (AML) Patients: Results of a Retrospective Single Centre Matched Analysis,
2011 · Elsa Lestang, Sameh Ayari, et al. · Blood · 3
Les personnes atteintes de la maladie de Parkinson font preuve de flexibilité phonétique
2022 · Véronique Delvaux, Bernard Harmegnies, et al. · Journées d'Études sur la Parole (JEP) · 2
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial
2022 · Jonas Dubu, Sébastien Boyas, et al. · JMIR Research Protocols · 1
PDF
An efficient multidisciplinary approach in a pregnant patient with hereditary spastic paraparesis treated by intrathecal baclofen therapy: A case report
2021 · Anaesthesiology CHU UCL NAMUR Site Godinne, Yvoir, Belgium., Fostier M, et al. · Journal of Clinical Images and Medical Case Reports · 1
PDF
Dynamique phonétique et contrôle moteur dans la maladie de Parkinson: analyse du contrôle de la production des glides
2016 · Roland, Virginie, Delvaux, Véronique, et al. · ORBi UMONS · 1
Long-Term Complications (LTC) and Quality of Life (QOL) After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT),
2011 · Aline Clavert, Peric Zina, et al. · Blood · 1
Longitudinal assessments of MRD in high‐risk newly diagnosed transplant‐ineligible multiple myeloma in the BENEFIT study (IFM2020‐05)
2026 · Jill Corre, Jerome Lambert, et al. · HemaSphere
PDF
First results of the rwe prospective study TEC care (IFM 2023-01) evaluating teclistamab in triple-class exposed relapsed refractory multiple myeloma patients.
2025 · Aurore Perrot, Cyrille Hulin, et al. · Blood
The Boutchou project: adapting the MonPaGe tool to a pediatric population
2025 · Piccaluga, Myriam, Deghorain, Pauline, et al. · ORBi UMONS
PDF
Works count: 46
Citation count: 383
H-index: 12
I10-index: 13
Year
Topic
Type